一扇新的大门已经打开，但积累更多的临床证据来控制糖尿病伴射血分数保留的心衰仍然至关重要。
A new door opens, but it is essential to accumulate further clinical evidence to control heart failure in diabetes with preserved ejection fraction.
机构信息
Department of Endocrinology and Diabetes, Kusatsu General Hospital, Kusatsu, Shiga, Japan.
出版信息
J Diabetes Investig. 2019 Sep;10(5):1145-1147. doi: 10.1111/jdi.13107. Epub 2019 Jul 28.
Abstract
TBA.[Image: see text]
摘要
待确定。[图像：见正文]
相似文献
1
A new door opens, but it is essential to accumulate further clinical evidence to control heart failure in diabetes with preserved ejection fraction.一扇新的大门已经打开，但积累更多的临床证据来控制糖尿病伴射血分数保留的心衰仍然至关重要。
J Diabetes Investig. 2019 Sep;10(5):1145-1147. doi: 10.1111/jdi.13107. Epub 2019 Jul 28.
2
Causes and pathophysiology of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的病因及病理生理学
Heart Fail Clin. 2014 Jul;10(3):389-98. doi: 10.1016/j.hfc.2014.04.002. Epub 2014 May 22.
3
HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward?射血分数保留的心力衰竭：按合并症将其分为不同表型是前进的方向吗？
J Am Coll Cardiol. 2014 Aug 12;64(6):550-2. doi: 10.1016/j.jacc.2014.06.010.
4
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).根据心力衰竭和射血分数保留患者的糖尿病状态的临床和超声心动图特征和心血管结局：来自 I-Preserve 试验（伊贝沙坦治疗射血分数保留心力衰竭）的报告。
Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593. Epub 2017 Jan 4.
5
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.射血分数降低、中间范围和保留的心衰中的非心脏合并症。
Int J Cardiol. 2018 Nov 15;271:132-139. doi: 10.1016/j.ijcard.2018.04.001. Epub 2018 Jul 7.
6
Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure.心力衰竭患者中射血分数降低、中等范围及保留的无症状性脑梗死
Arq Bras Cardiol. 2018 Sep;111(3):419-422. doi: 10.5935/abc.20180140.
7
Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.糖尿病性心肌病：射血分数保留的B期心力衰竭的一种表现。
Diab Vasc Dis Res. 2015 Jul;12(4):234-8. doi: 10.1177/1479164115579006. Epub 2015 Apr 23.
8
Murine models of diastolic dysfunction and heart failure with preserved ejection fraction.舒张功能障碍和射血分数保留的心力衰竭的小鼠模型。
J Card Fail. 2014 Dec;20(12):984-95. doi: 10.1016/j.cardfail.2014.09.001. Epub 2014 Sep 16.
9
Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.急性心肌梗死患者左心室射血分数保留的心力衰竭
Arq Bras Cardiol. 2015 Aug;105(2):145-50. doi: 10.5935/abc.20150055. Epub 2015 May 29.
10
Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.糖尿病治疗的心肌靶点在射血分数保留或降低的心力衰竭中不同。
JACC Heart Fail. 2018 Jan;6(1):1-7. doi: 10.1016/j.jchf.2017.07.012.
引用本文的文献
1
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.糖尿病和代谢性心血管疾病中的微血管功能障碍。
Endocr Rev. 2021 Jan 28;42(1):29-55. doi: 10.1210/endrev/bnaa025.
2
Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.钠-葡萄糖共转运蛋白 2 抑制剂代表了 2 型糖尿病患者心力衰竭预防的范式转变。
J Diabetes Investig. 2021 Jan;12(1):6-20. doi: 10.1111/jdi.13329. Epub 2020 Aug 5.
本文引用的文献
1
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.卡格列净对2型糖尿病患者射血分数保留和降低的心衰结局的影响。
Circulation. 2019 May 28;139(22):2591-2593. doi: 10.1161/CIRCULATIONAHA.119.040057. Epub 2019 Mar 17.
2
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients.糖尿病患者舒张功能障碍的分子机制。
Int J Mol Sci. 2019 Mar 9;20(5):1197. doi: 10.3390/ijms20051197.
3
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.糖尿病和微血管并发症对射血分数保留的心力衰竭患者预后的意义。
Diabetes Care. 2018 Jan;41(1):150-155. doi: 10.2337/dc17-0755. Epub 2017 Oct 19.
4
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.糖尿病对射血分数降低和保留的心力衰竭患者预后的影响：心力衰竭中坎地沙坦：降低死亡率和发病率评估（CHARM）项目分析
Eur Heart J. 2008 Jun;29(11):1377-85. doi: 10.1093/eurheartj/ehn153. Epub 2008 Apr 14.
5
Diabetic cardiomyopathy.糖尿病性心肌病
Diabetes Care. 2003 Oct;26(10):2949-51. doi: 10.2337/diacare.26.10.2949.
6
New type of cardiomyopathy associated with diabetic glomerulosclerosis.与糖尿病性肾小球硬化相关的新型心肌病。
Am J Cardiol. 1972 Nov 8;30(6):595-602. doi: 10.1016/0002-9149(72)90595-4.
Zotero 插件